Susquehanna International Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.12M Buy
162,436
+148,977
+1,107% +$2.93M ﹤0.01% 5194
2025
Q4
$255K Buy
13,459
+3,393
+34% +$62.9K ﹤0.01% 10323
2025
Q3
$188K Sell
10,066
-277,611
-97% -$5.19M ﹤0.01% 11061
2025
Q2
$5.3M Buy
287,677
+6,549
+2% +$116K ﹤0.01% 3867
2025
Q1
$4.91M Buy
281,128
+163,898
+140% +$2.76M ﹤0.01% 3686
2024
Q4
$2.03M Buy
117,230
+91,032
+347% +$1.66M ﹤0.01% 5291
2024
Q3
$488K Buy
26,198
+3,146
+14% +$53K ﹤0.01% 8522
2024
Q2
$355K Buy
23,052
+11,114
+93% +$159K ﹤0.01% 9091
2024
Q1
$176K Sell
11,938
-98,609
-89% -$1.37M ﹤0.01% 10737
2023
Q4
$1.58M Buy
110,547
+88,956
+412% +$1.26M ﹤0.01% 5874
2023
Q3
$301K Sell
21,591
-68,321
-76% -$874K ﹤0.01% 9343
2023
Q2
$1.06M Sell
89,912
-20,196
-18% -$230K ﹤0.01% 6547
2023
Q1
$1.27M Buy
110,108
+90,869
+472% +$1.12M ﹤0.01% 6211
2022
Q4
$239K Sell
19,239
-50,595
-72% -$645K ﹤0.01% 9682
2022
Q3
$916K Buy
69,834
+53,580
+330% +$792K ﹤0.01% 6859
2022
Q2
$227K Buy
16,254
+4,308
+36% +$57.6K ﹤0.01% 10317
2022
Q1
$178K Sell
11,946
-75,849
-86% -$1.04M ﹤0.01% 11380
2021
Q4
$1.19M Buy
87,795
+65,439
+293% +$926K ﹤0.01% 6832
2021
Q3
$329K Buy
22,356
+9,027
+68% +$152K ﹤0.01% 10383
2021
Q2
$243K Sell
13,329
-26,147
-66% -$466K ﹤0.01% 11199
2021
Q1
$685K Sell
39,476
-11,056
-22% -$194K ﹤0.01% 8725
2020
Q4
$878K Sell
50,532
-6,440
-11% -$103K ﹤0.01% 7022
2020
Q3
$785K Buy
56,972
+5,771
+11% +$84.8K ﹤0.01% 6709
2020
Q2
$739K Sell
51,201
-60,482
-54% -$795K ﹤0.01% 6554
2020
Q1
$1.22M Buy
111,683
+81,886
+275% +$1.51M ﹤0.01% 4929
2019
Q4
$636K Sell
29,797
-64,581
-68% -$1.45M ﹤0.01% 6468
2019
Q3
$2.17M Buy
94,378
+4,741
+5% +$101K ﹤0.01% 4027
2019
Q2
$1.76M Buy
89,637
+70,083
+358% +$1.37M ﹤0.01% 4424
2019
Q1
$381K Sell
19,554
-10,507
-35% -$199K ﹤0.01% 6792
2018
Q4
$495K Buy
+30,061
New +$605K ﹤0.01% 6053
2018
Q3
Sell
-19,033
Closed -$431K 10101
2018
Q2
$414K Buy
+19,033
New +$372K ﹤0.01% 7185
2018
Q1
Sell
-176,704
Closed -$3.11M 10060
2017
Q4
$3.32M Buy
176,704
+50,836
+40% +$1.01M ﹤0.01% 3080
2017
Q3
$2.76M Buy
+125,868
New +$2.84M ﹤0.01% 3357
2017
Q2
Sell
-64,671
Closed -$1.64M 9743
2017
Q1
$1.81M Sell
64,671
-28,009
-30% -$734K ﹤0.01% 3924
2016
Q4
$2.26M Buy
+92,680
New +$2.12M ﹤0.01% 3819
2016
Q2
Sell
-11,391
Closed -$237K 9226
2016
Q1
$229K Buy
+11,391
New +$218K ﹤0.01% 7743
2015
Q4
Sell
-10,885
Closed -$252K 9892
2015
Q3
$252K Sell
10,885
-1,488
-12% -$38K ﹤0.01% 8327
2015
Q2
$318K Buy
+12,373
New +$351K ﹤0.01% 8437
2015
Q1
Sell
-17,314
Closed -$526K 9870
2014
Q4
$526K Buy
+17,314
New +$477K ﹤0.01% 7109
2014
Q3
Sell
-18,726
Closed -$519K 9875
2014
Q2
$538K Buy
+18,726
New +$544K ﹤0.01% 7322
2014
Q1
Sell
-10,645
Closed -$278K 9350
2013
Q4
$278K Buy
+10,645
New +$274K ﹤0.01% 7701

Other funds holding SBRA

Susquehanna International Group's SBRA Position: Q1 2026 in Review

Susquehanna International Group increased its Sabra Healthcare REIT (SBRA) stake by 1,107% in Q1 2026, buying an estimated $2.93M and bringing the position to 162,436 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #5194.

Susquehanna International Group first reported a position in SBRA in Q4 2013 and has held it in 41 quarters since. The position peaked at $5.3M in Q2 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Susquehanna International Group held 162,436 shares of Sabra Healthcare REIT worth $3.12M as of Q1 2026.
  • Susquehanna International Group bought 148,977 Sabra Healthcare REIT shares in Q1 2026, an estimated $2.93M.
  • Sabra Healthcare REIT made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5194 holding.
  • Susquehanna International Group first reported a position in Sabra Healthcare REIT in Q4 2013 and has held it in 41 quarters since.
  • Susquehanna International Group's Sabra Healthcare REIT position peaked at $5.3M in Q2 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.